🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed as a Phase III, double-blind, multi-center, randomize...
Status
Unknown
Location
Center for Vaccine Development
Start Date
2022-09-16
Trial ID
NCT05447377
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
Investigating cytotoxicity of yellow fever specific CD8 T cells following Y...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2019-10-08
Trial ID
NCT04083430
Treatments Being Tested
This study will assess the coadministration of genetically attenuated Plasm...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2023-02-03
Trial ID
NCT05468606
Treatments Being Tested
ANRS 0146s NovaaTen study aims to determine the vaccine responses in the pa...
Status
Unknown
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT05450770
Treatments Being Tested
The purpose of this study is to obtain safety, tolerability, and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00982137
The purpose of this study is to determine whether vYF (investigational vacc...
Status
Recruiting
Location
Investigational Site Number : 3400001
Start Date
2025-07-11
Trial ID
NCT07103148
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
Main objective : To develop the tools for evaluation of humoral and cell-m...
Status
Completed
Location
Voir Liste Des Centres
Start Date
2011-07
Trial ID
NCT01426243
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety, and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-10
Trial ID
NCT02699099
Treatments Being Tested